English translation of content medically reviewed in Romanian by Dr. Claudiu Ruscu, intensive care physician (anaesthesia & intensive care)· Romanian text reviewed 20 September 2026
400RON
Consultation included if you go ahead · otherwise 200 RON
or message us on WhatsAppCertified doctors · Payment at the clinic
A double dose of glutathione for intensive antioxidant support. Recommended after periods of excess or prolonged exertion.
Available at the clinic or at home in Bucharest & Ilfov. See all prices.

The indication is decided at the medical assessment, based on your history, test results and goals. The doctor tells you whether this protocol is right for you.
The full list of contraindications is discussed during the consultation.
Glutathione 1200 mg
The dose is adjusted individually, based on the medical consultation. Every substance is pharmaceutical grade, given intravenously for higher bioavailability.
We assess your health and decide whether this protocol is right for you.
You are seated comfortably. The IV cannula is placed and monitoring begins.
The infusion is given slowly, under medical monitoring, for optimal tolerability.
Afterwards, we check how you are feeling. You can leave straight away.
1200 mg is the double dose, for more intensive antioxidant support. It is given somewhat more slowly than the standard dose, under medical supervision. Which dose suits you is decided at your consultation, depending on your goal and your assessment.
Usually 30-45 minutes, given slowly for the best tolerance. The doctor adjusts the rate along the way, and you are monitored from start to finish.
Usually there are no particular sensations; some people notice a faint, passing sulphur-like smell. Most people go back to their usual activities straight afterwards. Any discomfort is managed by adjusting the rate.
Yes: pregnancy and breastfeeding, severe kidney failure, known allergies to any of the components and severe active infections. They are checked in full at the medical consultation, before the drip is given.
400 RON, medical assessment included. Available at the clinic or at home in Bucharest and Ilfov, with the price published transparently.
English translation of answers medically reviewed in Romanian. They do not replace a consultation — indications and contraindications are decided individually, at the medical assessment.
The studies below support the statements on mechanism, pharmacokinetics and safety on this page. They do not support a guaranteed therapeutic outcome — each one is followed by its limitation.
[1] Forman HJ, Zhang H, Rinna A Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009.
narrative review · PMID 18796312
Limitation: A short narrative biochemistry review, the introduction to a themed issue. It describes the function of the glutathione the body produces, not the effect of glutathione given from outside. It does not discuss the liver specifically.
[2] Witschi A, Reddy S, Stofer B, et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992.
case series · sample: 7 · PMID 1362956
Limitation: Only 7 volunteers and a single dose, followed for 4.5 hours. It did not test long-term daily use, which gave a different result in a 2015 randomised trial (Richie). Analytical methods from 1992.
[3] Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015.
randomised trial · sample: 54 · PMID 24791752
Limitation: The outcome is a marker (the glutathione level), not a clinical benefit. The participants were healthy adults, and the effect disappeared after a one-month break. The study does not compare with intravenous administration.
[4] Aebi S, Assereto R, Lauterburg BH High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest. 1991.
case series · sample: 10 · PMID 1907548
Limitation: A single, high dose (2 g/m², about 3.5 g, 3–6 times above Synerva's protocols), in 10 volunteers. Glutathione inside the cells was not measured, and the methods date from 1991.
[5] Hauser RA, Lyons KE, McClain T, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. Mov Disord. 2009.
randomised trial · sample: 21 · PMID 19230029
Limitation: 21 patients with Parkinson's disease, not healthy people, treated for only 4 weeks. The group is too small to pick up rare allergic or anaphylactic reactions.
[6] Marrades RM, Roca J, Barberà JA, et al. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med. 1997.
randomised trial · sample: 8 · PMID 9279219
Limitation: The route is inhaled, not intravenous, so its relevance to the drip is indirect. Only 8 patients. It supports caution in asthma, not a reaction rate for IV administration.
[7] Sarkar R, Yadav V, Yadav T, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol. 2025.
systematic review · PMID 39444151
Limitation: The search covered only the last 10 years, and the included studies are small, half of them at high risk of bias. For the IV route there is a single study with 16 people per arm. Most of the data concern the oral and topical forms.
[8] Sonthalia S, Daulatabad D, Sarkar R Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. 2016.
narrative review · PMID 27088927
Limitation: A narrative review, not a systematic one. For the FDA Philippines warning it is a secondary source: the number and date of the warning are not given in the abstract. Adverse effects are not quantified.
We use necessary cookies and, only with your consent, analytics and marketing cookies.We use cookies to improve your experience on this site. Strictly necessary cookies are always on. You can also accept analytics and marketing cookies, or decline them. Details